-+ 0.00%
-+ 0.00%
-+ 0.00%

Vanda Pharmaceuticals SVP, General Counsel and Secretary Daniel McGuire files initial beneficial ownership statement

PUBT·06/08/2026 20:13:02
Listen to the news
Vanda Pharmaceuticals SVP, General Counsel and Secretary Daniel McGuire files initial beneficial ownership statement
  • Vanda Pharmaceuticals SVP, general counsel and secretary Daniel Patrick McGuire filed a Form 3 reporting 29,982 shares of common stock.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-261752), on June 08, 2026, and is solely responsible for the information contained therein.